In ALI, ferroptosis inducers can exacerbate pulmonary edema and alveolar inflammation, along with high levels of cytokines (IL-1β, IL-6, and TNF-α), which can be reversed by ferroptosis inhibitors [40–42]. Here, IL1B is linked to acute respiratory distress syndrome.